Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Novartis AG (NVS) vs NEOS S&P 500 High Income ETF (SPYI) Price & Performance

Novartis AGTrade
NEOS S&P 500 High Income ETFTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs NEOS S&P 500 High Income ETF — how do they compare? Novartis AG trades at $152.38 (market cap $295.37B), while NEOS S&P 500 High Income ETF trades at $54.19. The key difference: Novartis AG pays a 3.07% dividend while NEOS S&P 500 High Income ETF pays none, and NEOS S&P 500 High Income ETF is trading nearer its 52-week high, Novartis AG nearer its low. Which is the better fit depends on your goals.

NVSSPYI
Market Cap
$295.37B
Sector
HealthIncome / Options Overlay
52-Week High
$168.62$54.19
52-Week Low
$119.31$47.98
Enterprise Value
$336.69B
Dividend Yield
3.07%

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.

Read more on NVS

About NEOS S&P 500 High Income ETF

SPYI is an actively managed ETF designed to generate high monthly income through a data-driven call option strategy on the S&P 500 Index. Unlike traditional covered call funds that often forfeit significant upside, SPYI utilizes a 'call spread' approach—selling near-the-money calls while buying out-of-the-money calls—to capture a portion of equity appreciation in rising markets. It prioritizes tax efficiency by utilizing Section 1256 contracts and tax-loss harvesting to provide investors with high-yield monthly distributions.

Read more on SPYI